T-cell receptor gene-modified cells: past promises, present methodologies and future challenges

Area of Science:

• Immunology
• Cell Therapy
• Molecular Biology

Background:

• Immunotherapy is a rapidly advancing field.
• Genetically modified T-cell receptors (TCRs) enable T-lymphocyte populations with specific targeting capabilities.
• TCR-modified T cells offer a promising approach for antigen-specific T-cell therapy.

Purpose of the Study:

• To review the characteristics of TCR gene-modified cells.
• To discuss their clinical applications and potential in adoptive cell transfer (ACT).
• To outline manufacturing, characterization, and challenges for clinical translation.

Main Methods:

• Review of existing literature on TCR gene modification.
• Analysis of TCR-engineered T-cell characteristics and MHC restriction.
• Discussion of manufacturing and characterization protocols.

Main Results:

• High-affinity TCRs can be engineered to enhance efficacy and minimize adverse events.
• TCR-modified T cells can target diverse self and non-self antigens.
• TCRs present a viable alternative to chimeric antigen receptors (CARs) in certain contexts.

Conclusions:

• TCR gene-modified cells hold significant promise for adoptive cell transfer (ACT).
• Overcoming manufacturing and clinical translation challenges is crucial for broader application.
• Further research is needed to fully realize the therapeutic potential of TCR-based immunotherapies.